Results 1 to 10 of about 447,676 (302)
Growth hormone therapy in HHRH
Bone Reports, 2022 Background: Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) (SLC34A3 gene, OMIM 241530) is an autosomal recessive disorder that results in a loss of function of the sodium-phosphate NPT2c channel at the proximal tubule.
Guido Filler, MD, PhD +6 more
doaj +3 more sources
A female survivor of childhood medulloblastoma presenting with growth-hormone-induced edema and inflammatory lesions: a case report [PDF]
Journal of Medical Case Reports, 2009 Introduction The improved survival of children with brain tumors has increased concerns about treatment-related sequelae. Growth hormone deficiency is frequently observed after craniospinal irradiation for medulloblastoma.
Biassoni Veronica +7 more
doaj +2 more sources
Optimization of growth hormone therapy in growth hormone deficient children [PDF]
The Indian Journal of Pediatrics, 1991 It is obvious that the results published so far as well as the present preliminary data do not answer many questions regarding the optimal therapeutic regimen in GH deficiency. In particular, long-term follow-up must be organized to evaluate efficacy and safety of GH therapy not only in GHD but also for the “new” indications such as Turner syndrome ...
Muinck Keizer-Schrama, S.M.P.F. (Sabine) de
core +11 more sources
History of growth hormone therapy
Indian Journal of Endocrinology and Metabolism, 2011 Although the importance of the pituitary gland for growth was recognized in late 19 th century, Growth hormone (GH) therapy was made available for severely GH-deficient children and adolescents only in late 1950s.
Vageesh S Ayyar
doaj +5 more sources
Children with craniopharyngioma resection had better response to recombinant human growth hormone therapy than those with idiopathic short stature [PDF]
Frontiers in EndocrinologyObjectiveTo compare growth response and rhGH dosage requirements between children with craniopharyngioma post-resection (CP group, n=18) and those with idiopathic short stature (ISS group, n=18).MethodsA retrospective analysis (2010–2020) was conducted ...
Ting Li +5 more
doaj +2 more sources
Growth Hormone Therapy in Neurosecretory Dysfunction. [PDF]
Turk Arch PediatrObjective: Growth hormone neurosecretory dysfunction (GH-NSD) is a rare cause of short stat- ure. Diagnosis is established by evaluating nocturnal growth hormone secretion in patients with normal growth hormone stimulation tests. The aim of this study was to evaluate the first- and second-year treatment responses and final height in patients diagnosed ...
Çetiner EB +6 more
europepmc +3 more sources
Frontiers in Endocrinology, 2021 BackgroundWe performed a meta-analysis to evaluate the efficacy and safety of weekly long-acting growth hormone replacement therapy compared to daily growth hormone in children with short stature.MethodsA systematic literature search up to April 2021 was
Liyan Ma +6 more
doaj +1 more source
Advanced Medical Journal, 2023 Background and objectives: To find out the response to growth hormone therapy among growth hormone deficiency patients with different causes and to find out the role of insulin-like growth factor one in monitoring response.
Kawes Omer Zangana +2 more
doaj +1 more source
Efficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2014 PurposeGrowth hormone (GH) plays a key role in the regulation of body composition, lipid metabolism, and quality of life in adults with GH deficiency (GHD).
Ja Hye Kim +3 more
doaj +1 more source
Trends in Pediatrics, 2021 Objective: A small number of studies were reported regarding the direct and indirect effects of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) especially on the erythrocyte series. The purpose of this study was to examine the effects of GH
Derya Şengün, Atilla Çayır
doaj +1 more source